BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
China's GLP-1 landscape
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
PFA re-energizes afib market
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, November 8, 2024
See today's BioWorld Asia
Home
» Other news to note for Dec. 20, 2022
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Other news to note for Dec. 20, 2022
Dec. 20, 2022
No Comments
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Asieris, Astrazeneca, Axcella, Basilea, Bioxytran, Calliditas, Eisai, Fuji Yakuhin, Glycotope, Lianbio, Merck, Pfizer, Phoremost, Photocure, Sillajen, Sosei, Sumitomo, Therabest, Thinkcyte, Urica, Viatris, Woodward Pharma Services, Zhejiang Doer Biologics.
BioWorld Asia
Briefs
Other news to note